The American Journal of Medicine
Volume 122, Issue 5 , Page e15 , May 2009

Improved Outcomes in Community-acquired Pneumonia with Prior Statin Use

References 

  1. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med. 2008;121:1002–1007e1
  2. Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy (An evaluation of current recommendations). JAMA. 1993;270:1826–1831
  3. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994;121:947–952
  4. Maciosek MV, Solberg LI, Coffield AB, et al. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Am J Prev Med. 2006;31:72–79
  5. de Diego C, Vila-Córcoles A, Ochoa O, et al. EPIVAC Study Group Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J. 2009;30:209–216Epub 2008 Nov 8
  6. Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis. 2008;47:1328–1338
  7. Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med. 2008;168:666–667

PII: S0002-9343(09)00053-9

doi: 10.1016/j.amjmed.2008.12.015

The American Journal of Medicine
Volume 122, Issue 5 , Page e15 , May 2009

Article Tools